Shanghai Yizhong Pharmaceutical Co Ltd (688091) - Total Liabilities

Latest as of September 2025: CN¥82.76 Million CNY ≈ $12.11 Million USD

Based on the latest financial reports, Shanghai Yizhong Pharmaceutical Co Ltd (688091) has total liabilities worth CN¥82.76 Million CNY (≈ $12.11 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688091 operating cash flow to assess how effectively this company generates cash.

Shanghai Yizhong Pharmaceutical Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Shanghai Yizhong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Shanghai Yizhong Pharmaceutical Co Ltd (688091) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Shanghai Yizhong Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Yizhong Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Okeanis Eco Tankers Corp. NYSE:ECO	USA	$637.29 Million
Beijer Alma AB (publ) ST:BEIA-B	Sweden	Skr5.10 Billion
Stx Engine KO:077970	Korea	₩767.15 Billion
Thanachart Capital Public Company Limited BK:TCAP-R	Thailand	฿76.27 Billion
Com7 PCL BK:COM7	Thailand	฿17.10 Billion
CMST Development Co Ltd SHG:600787	China	CN¥9.18 Billion
GIMV NV BR:GIMB	Belgium	€422.95 Million
Guangdong Ellington Electronics Technology Co Ltd SHG:603328	China	CN¥2.33 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Shanghai Yizhong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Yizhong Pharmaceutical Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Yizhong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual total liabilities of Shanghai Yizhong Pharmaceutical Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥42.97 Million ≈ $6.29 Million	-60.40%
2023-12-31	CN¥108.52 Million ≈ $15.88 Million	+206.43%
2022-12-31	CN¥35.42 Million ≈ $5.18 Million	+41.54%
2021-12-31	CN¥25.02 Million ≈ $3.66 Million	+63.50%
2020-12-31	CN¥15.30 Million ≈ $2.24 Million	+24.79%
2019-12-31	CN¥12.26 Million ≈ $1.79 Million	-28.49%
2018-12-31	CN¥17.15 Million ≈ $2.51 Million	+6.02%
2017-12-31	CN¥16.17 Million ≈ $2.37 Million	--

About Shanghai Yizhong Pharmaceutical Co Ltd

SHG:688091 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.67 Billion

CN¥11.44 Billion CNY

Market Cap Rank

#6918 Global

#1601 in China

Share Price

CN¥55.35

Change (1 day)

+0.73%

52-Week Range

CN¥41.20 - CN¥81.75

All Time High

CN¥95.97